$REPL 3 SEC Filings

Filed On	Filing
07 Mar 2025	Form 3: Goller Michael, Director No securities owned
07 Mar 2025	Form 3: Baker Bros. Advisors Lp, Director and 5 others Holds 929,241 shares of Common Stock
05 Sep 2024	Form 3: Balachandran Madhavan, Director No securities owned
20 Sep 2023	Form 3: Hill Emily Luisa, Chief Financial Officer No securities owned
26 Jul 2023	Form 3: Sarchi Christopher, Chief Commercial Officer Holds 55,000 shares of Common Stock
05 Jun 2023	Form 3: Peeples-Dyer Veleka, Director No securities owned
18 May 2023	Form 3: Schwendenman Andrew, Chief Accounting Officer Holds 22,761 shares of Common Stock
05 Dec 2022	Form 3: Xynos Konstantinos, Chief Medical Officer Holds 37,500 shares of Common Stock
03 Dec 2021	Form 3: Oliger Christy J., Director No securities owned
05 May 2021	Form 3: Patel Sushil, Chief Commercial Officer No securities owned
03 Nov 2020	Form 3: Lewis Tanya, Director No securities owned
22 Jul 2020	Form 3: Pirzkall Andrea, Chief Medical Officer Holds 1,000 shares of Common Stock
02 Apr 2020	Form 3: Pucci Paolo, Director No securities owned
11 Dec 2019	Form 3: Franchi Jean M., Chief Financial Officer No securities owned
20 Nov 2019	Form 3: Atlas Venture Opportunity Fund I, L.p., See Remarks and 2 others Holds 1,100,000 shares of Common Stock
19 Jul 2018	Form 3: Levitsky Hyam, Director No securities owned
19 Jul 2018	Form 3: Dhingra Kapil, Director
19 Jul 2018	Form 3: Weinand Dieter, Director No securities owned
19 Jul 2018	Form 3: Slattery Joseph P, Director
19 Jul 2018	Form 3: Esposito Pamela, Chief Business Officer

Comments